Dr. Yao highlights that approximately 2 million older adults in the US are permanently homebound, with cancer among the leading diagnoses, and many more experience frequent periods of functional decline or immobility. These patients face significant disparities in access to care, particularly racial and ethnic minorities who are more likely to die at home without adequate support.
Dr. Godley emphasizes the increasing recognition of germline predisposition in hematopoietic malignancies, challenging traditional assumptions that these genetic factors are rare. The talk includes a short Q&A discussion at the end.
Dr. Zimmer provides an in-depth exploration of brain metastases in breast cancer, emphasizing the challenges in management and evolving treatment strategies, outlining the clinical complexities associated with HER2-positive, triple-negative, and hormone receptor-positive breast cancers and their distinct metastatic patterns and treatment responses.
Dr. Jackson provides a detailed overview of current therapeutic options for COVID-19, distinguishing between outpatient and inpatient care strategies. Dr. Jackson emphasizes early treatment within the first five days of symptoms. Nirmatrelvir/ritonavir (Paxlovid) is highlighted as the preferred option due to its robust efficacy in preventing hospitalization and death. Remdesivir, administered over three days intravenously, is considered a suitable alternative for those unable to take Paxlovid.